Advertisement

Index by author

July 01, 1986; Volume 14,Issue 4

A

  1. Albert, A

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

  2. Andres, H H

    1. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
      H H Andres and W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 382-385;

B

  1. Baba, S

    1. Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;

  2. Baillie, T A

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;

  3. Barber, H E

    1. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;

  4. Barinov, I

    1. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

  5. Beaune, P H

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

  6. Benet, L Z

    1. Characterization of the isomeric esters of zomepirac glucuronide by proton NMR.
      P C Smith and L Z Benet
      Drug Metabolism and Disposition July 1986, 14 (4) 503-505;

  7. Bickers, D R

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

  8. Birnbaum, L S

    1. Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition July 1986, 14 (4) 417-422;

  9. Borghoff, S J

    1. Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition July 1986, 14 (4) 417-422;

  10. Brammer, J D

    1. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;

  11. Bygdeman, M

    1. Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

C

  1. Christensen, N J

    1. Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

D

  1. Das, M

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

  2. De Graeve, J

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

  3. Dimov, V

    1. Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

  4. Don, P S

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

  5. Dumont, P

    1. Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;

G

  1. Gerardy, B M

    1. Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;

  2. Gordon, W P

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;

  3. Gréen, K

    1. Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

  4. Gross, B

    1. Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;

  5. Guengerich, F P

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

H

  1. Hawksworth, G M

    1. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;

J

  1. James, M O

    1. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;

K

  1. Kaminsky, L S

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

  2. Kapusta, D

    1. Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;

  3. Kasuya, Y

    1. Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;

  4. Kick, C J

    1. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

  5. Kolis, S J

    1. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;

  6. Kremers, P G

    1. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

  7. Kumano, T

    1. Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;

L

  1. Levy, R H

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;

  2. Liu, A L

    1. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

  3. Lockard, J S

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;

M

  1. Mamada, K

    1. Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;

  2. Marcelo, C L

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

  3. Meacham, R H

    1. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

  4. Mehendale, H M

    1. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
      R A Young and H M Mehendale
      Drug Metabolism and Disposition July 1986, 14 (4) 423-429;

  5. Modly, C E

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

  6. Mukhtar, H

    1. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

N

  1. Nelson, W L

    1. Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures.
      W L Nelson and H U Shetty
      Drug Metabolism and Disposition July 1986, 14 (4) 506-508;

P

  1. Pathiratne, A

    1. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;

  2. Postma, E J

    1. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;

  3. Poupaert, J H

    1. Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;

  4. Prickett, K S

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;

  5. Puyear, R L

    1. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;

R

  1. Rettenmeier, A W

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;

  2. Rice, S A

    1. Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;

  3. Ruelius, H W

    1. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

S

  1. Salhab, A S

    1. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;

  2. Sasso, G J

    1. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;

  3. Schillings, R T

    1. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
      R T Schillings and S F Sisenwine
      Drug Metabolism and Disposition July 1986, 14 (4) 405-412;

  4. Serra, M T

    1. Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;

  5. Shetty, H U

    1. Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures.
      W L Nelson and H U Shetty
      Drug Metabolism and Disposition July 1986, 14 (4) 506-508;

  6. Shiverick, K T

    1. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;

  7. Sisenwine, S F

    1. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
      R T Schillings and S F Sisenwine
      Drug Metabolism and Disposition July 1986, 14 (4) 405-412;
    2. Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

  8. Smith, P C

    1. Characterization of the isomeric esters of zomepirac glucuronide by proton NMR.
      P C Smith and L Z Benet
      Drug Metabolism and Disposition July 1986, 14 (4) 503-505;

T

  1. Thummel, K E

    1. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;

U

  1. Uematsu, T

    1. Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;

W

  1. Walker, K A

    1. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;

  2. Wallace, K B

    1. Aglycosylation and disposition of doxorubicin in isolated rat liver nuclei and microsomes.
      K B Wallace
      Drug Metabolism and Disposition July 1986, 14 (4) 399-404;

  3. Wang, S L

    1. Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;
    2. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;

  4. Weber, W W

    1. The molecular basis of hereditary acetylation polymorphisms.
      W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 377-381;
    2. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
      H H Andres and W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 382-385;

  5. Williams, T H

    1. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;

Y

  1. Yoshioka, T

    1. Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;

  2. Young, R A

    1. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
      R A Young and H M Mehendale
      Drug Metabolism and Disposition July 1986, 14 (4) 423-429;
Back to top

In this issue

Advertisement